Divestment
Imcyse
Imcyse develops active specific immunotherapies for the treatment and prevention of severe chronic diseases.
Key Facts
- Sector
Life Sciences
- Country
Belgium
- Fund
LSP 6
- Entry
2019
- Exit
2025
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.
